Home › Chemotherapy › Nab-Paclitaxel (Abraxane, Nabtaxel): — How It Differs and What It Costs

Chemotherapy · Taxane family

Nab-Paclitaxel (Abraxane, Nabtaxel): How It Differs and What It Costs

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Nab-paclitaxel contains the same active drug as conventional paclitaxel, but delivers it using albumin instead of an oily solvent. That change removes the premedication step — and adds a considerable cost.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Prescription-only medicine.

Nab-paclitaxel is a prescription-only chemotherapy given only in a hospital or day-care unit under the direct supervision of a specialist oncologist. Nothing on this page can be used to start, change, or stop treatment. Speak with your treating oncologist before making any decision about your care. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Nab-paclitaxel (Abraxane, Nabtaxel in India) is paclitaxel attached to albumin nanoparticles. The albumin carrier replaces an oily solvent that conventional paclitaxel requires, removing the need for premedication before each infusion. The tradeoff is cost: nab-paclitaxel is considerably more expensive than standard paclitaxel.

In detail

What is nab-paclitaxel and how is it different from regular paclitaxel?

Conventional paclitaxel cannot dissolve in water. It is prepared in an oily solvent called Cremophor EL, which often triggers allergic reactions — sometimes severe ones. This is why patients need steroids and antihistamines before each infusion.

Nab-paclitaxel (Abraxane, Nabtaxel) takes the same paclitaxel molecule and binds it to albumin nanoparticles. Albumin is a protein your body already produces. The switch removes Cremophor from the equation, which removes the premedication step.

The infusion is also shorter than conventional paclitaxel. Your team will confirm the exact schedule for your regimen.

In detail

Why does nab-paclitaxel cost considerably more than conventional paclitaxel?

The higher price reflects how it is made. Binding paclitaxel to albumin nanoparticles at a precise size requires specialised manufacturing, and that complexity adds cost.

Nabtaxel, manufactured in India by Natco Pharma, is available at a lower price than the originator brand Abraxane. Both contain the same active molecule and use the same albumin-nanoparticle technology. Your treating centre will confirm which brand they use.

Any cost figure quoted online is indicative and quickly outdated. Ask the hospital billing team for a written estimate covering your planned number of cycles before treatment begins.

Eligibility

Who this medicine is not for

Nab-paclitaxel is not suitable for everyone. Eligibility is decided by an oncologist based on the individual case, not by reading about it online.

People with known hypersensitivity to paclitaxel or to albumin, the protein used as its carrier.
People with severe pre-existing peripheral neuropathyNerve damage causing numbness, tingling or pain in the hands and feet — because this medicine can worsen it.
People with severely impaired liver function, as nab-paclitaxel is processed by the liver.
People whose blood counts are too low before a planned cycle; treatment is typically deferred until counts recover.
Women who are pregnant or breastfeeding.

Your oncologist will assess your blood counts, liver function, nerve health and overall fitness before recommending this medicine.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

Question by question

What families commonly ask about nab-paclitaxel

Is nab-paclitaxel stronger or better than regular paclitaxel?

The active drug molecule is the same in both. Nab-paclitaxel is not chosen because it is inherently stronger, but because the albumin-bound formulation suits certain cancer types and situations — for example where the cancer type has an established indication for this formulation, or where repeated hypersensitivity reactions made conventional paclitaxel difficult to give. Your oncologist will explain which formulation is recommended for your specific situation and why one was chosen over the other.

What side effects does nab-paclitaxel cause?

The most common side effects include peripheral neuropathy (numbness, tingling or pain in the hands and feet), hair loss, low blood counts, fatigue, nausea, and muscle or joint aches. NCCN guidance notes that peripheral neuropathy may occur more frequently with nab-paclitaxel than with conventional paclitaxel, though this varies between individuals. Report any new numbness or tingling to your team promptly — it is among the effects they watch most carefully, and early reporting can change how your dose is managed.

Why is no premedication needed before nab-paclitaxel?

Conventional paclitaxel dissolved in Cremophor EL frequently triggers hypersensitivity reactions — including flushing, rash, difficulty breathing, or drops in blood pressure. Steroid and antihistamine premedication reduces but does not eliminate that risk. Nab-paclitaxel uses albumin instead of Cremophor, removing the main hypersensitivity trigger. Because the solvent is absent, routine premedication is not required before most nab-paclitaxel infusions, though your team may still give other supportive medicines depending on your individual situation.

If Nabtaxel is cheaper, is it less effective than Abraxane?

Nabtaxel is a licensed version of nab-paclitaxel manufactured in India by Natco Pharma under the same albumin-nanoparticle technology as the originator. Regulatory approval of a generic in this category requires demonstrated bioequivalence — meaning the drug is expected to behave the same way in the body. Your oncologist's recommendation will be based on clinical grounds. Cost may also factor into which brand your treating centre uses, but that is a separate decision from clinical appropriateness.

Can you ask to switch from conventional paclitaxel to nab-paclitaxel?

A switch between formulations is a clinical decision made by your oncologist, not one initiated by the patient. It may be considered if repeated hypersensitivity reactions have made conventional paclitaxel difficult to tolerate, or for a clinical reason specific to your situation. It is not simply an upgrade — the two formulations have different side-effect profiles, and switching for preference or cost reasons alone is not standard practice. If you want to understand the choice of formulation, put the question directly to your oncology team at your next visit.

Worth knowing

Did you know?

Before albumin-bound paclitaxel was developed, the oily solvent Cremophor EL — used to dissolve conventional paclitaxel — made premedication with steroids and antihistamines a standard part of chemotherapy visits worldwide.

Nab-paclitaxel was developed specifically to remove that solvent and the hypersensitivity risk it carried.

Source: FDA prescribing information for nab-paclitaxel (albumin-bound)

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

What cancers is nab-paclitaxel used for?

Nab-paclitaxel is used in several cancer types, most commonly breast cancer, non-small cell lung cancer, and pancreatic cancer — often in combination with other chemotherapy medicines. The specific cancer types and combinations it is recommended for are set out in guidance from NCCN, ASCO and ESMO. Your oncologist will match the recommendation to your diagnosis, stage and prior treatment history.

How is nab-paclitaxel given?

Nab-paclitaxel is given as an intravenous infusion in a hospital or day-care chemotherapy unit under specialist supervision. It is never taken as a tablet or self-administered at home. Your oncologist will set the schedule — how often, in what combination, and for how many cycles — based on your cancer type and treatment plan. Each visit includes pre-infusion blood count checks.

Is nab-paclitaxel covered under Ayushman Bharat or other government schemes?

Coverage varies considerably. Some government and state schemes cover the Indian-manufactured version Nabtaxel but not the originator Abraxane; others may require prior authorisation before any brand is approved. Employer and private insurance policies also differ. Ask your hospital's billing or insurance liaison team exactly what is covered under your specific scheme before your first cycle, so there are no unexpected payments mid-treatment.

What blood tests are done before each cycle?

Before each cycle, your team checks your complete blood count — particularly the white cell and neutrophil count, which must reach a safe level before chemotherapy proceeds. Liver function tests may also be ordered. If counts are below the threshold your oncologist has set, the cycle is deferred. This is a standard safety step, not a setback, and your team will tell you exactly what they are looking for and when treatment can resume.

Can I take herbal or Ayurvedic medicines alongside nab-paclitaxel?

Some herbal and traditional medicines affect how chemotherapy is processed by the liver, which can change how much active drug reaches your bloodstream. This is not a reason to stop a practice your family follows — it is a reason to tell your oncology team everything you are taking, including supplements and traditional preparations. They can tell you specifically whether anything you take is known to interact with your chemotherapy regimen.

How will my team know if nab-paclitaxel is working?

Response is assessed through scans, blood markers, or clinical examination at intervals your oncologist sets — not by how you feel between appointments. Many people receiving chemotherapy notice no dramatic short-term change, and that absence does not mean the medicine is not working. Your team will tell you when the first formal assessment is planned and what they will be measuring at that point.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index